TLR3 agonists as immunotherapeutic agents-Reference-Cited by-同舟云学术

TLR3 agonists as immunotherapeutic agents

Published:2010-03 Issue:2 Volume:2 Page:137-140
ISSN:1750-743X
Container-title:Immunotherapy
language:en
Short-container-title:Immunotherapy

Author:

Nicodemus Christopher F¹,Berek Jonathan S²

Affiliation:

1. Advanced Immune Therapeutics, Inc., 47 River Street, Suite 100, Wellesley, MA 02481, USA.

2. Stanford University School of Medicine, Department of Obstetrics & Gynecology, Division of Gynecologic Oncology, Women’s Cancer Program, Stanford Cancer Center, Stanford, CA, USA.

Publisher

Future Medicine Ltd

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.futuremedicine.com/doi/pdf/10.2217/imt.10.8

Reference18 articles.

1. Toll-like receptor control of the adaptive immune responses

2. Subcellular Localization of Toll-Like Receptor 3 in Human Dendritic Cells

3. Human TSLP and TLR3 ligands promote differentiation of Th17 cells with a central memory phenotype under Th2-polarizing conditions

4. Human Langerhans’ cells and dermal-type dendritic cells generated from CD34 stem cells express different toll-like receptors and secrete different cytokines in response to toll-like receptor ligands

5. CONTRIBUTION TO THE KNOWLEDGE OF SARCOMA

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protective effect of β-glucan on Poly(I:C)-induced acute lung injury/inflammation: Therapeutic implications of viral infections in the respiratory system;Life Sciences;2023-10

2. <i>In vitro</i> antiviral activity of a double-stranded RNA sodium salt-based medicinal product against SARS-CoV-2;Biological Products. Prevention, Diagnosis, Treatment;2023-08-31

3. Paramyxoviruses: Henipaviruses;Viral Infections of Humans;2023

4. Design of a Recombinant Multivalent Epitope Vaccine Based on SARS-CoV-2 and Its Variants in Immunoinformatics Approaches;Frontiers in Immunology;2022-05-06

5. Rintatolimod Induces Antiviral Activities in Human Pancreatic Cancer Cells: Opening for an Anti-COVID-19 Opportunity in Cancer Patients?;Cancers;2021-06-09